Herriot Tabuteau is Chief Executive Officer, President, and Chairman of the Board of Axsome Therapeutics, Inc. (AXSM). The company reported total compensation of $10,283,492 for fiscal year 2025.
| Salary | $835,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $5,533,554 |
| Option awards | $2,833,237 |
| Non-equity incentive plan | $876,750 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $204,951 |
| Total | $10,283,492 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Axsome Therapeutics, Inc. filed April 24, 2026, accession 0001193125-26-177610.
| Peer-group chief executive median | $10,068,915 |
|---|---|
| Difference from that median | $214,577 |
| Percentile within the disclosed peer group | 57th |
| Peers with a disclosed figure | 6 |
Medians and percentiles are computed across the peer group Axsome Therapeutics, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Herriot Tabuteau this page | Chief Executive Officer, President, and Chairman of the Board | $10,283,492 |
| Mark Jacobson | Chief Operating Officer | $4,208,131 |
| Nick Pizzie | Chief Financial Officer | $3,730,519 |
| Hunter Murdock | General Counsel | $3,224,304 |
| Ari Maizel | Chief Commercial Officer | $3,188,657 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Axsome Therapeutics, Inc. compensation brief.
Herriot Tabuteau's compensation sits inside Axsome Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.